Chicago, IL, United States of America

Golam Kibria

This inventor holds 1 USPTO granted patent. Top assignees: Case Western Reserve University, Northwestern University. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Golam Kibria. Retrieved from https://idiyas.com/inventor/golam-kibria

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Golam Kibria: Innovator in Cancer Diagnostics and Therapeutics

Introduction

Golam Kibria is an accomplished inventor based in Chicago, IL. He has made significant contributions to the field of cancer diagnostics and therapeutics. His innovative work focuses on the use of exosomes for biomarker analysis, which is crucial for the early detection and characterization of cancer progression.

Latest Patents

Golam Kibria holds a patent for "Extracellular vesicle-based diagnostics and engineered exosomes for targeted therapeutics against cancer." This invention utilizes bioengineered exosomes to enhance methods for targeting and treating cancer, providing a promising avenue for future cancer therapies.

Career Highlights

Throughout his career, Kibria has worked with prestigious institutions such as Case Western Reserve University and Northwestern University. His experience in these research environments has allowed him to develop groundbreaking technologies that address critical challenges in cancer treatment.

Collaborations

Some of his notable coworkers include Huiping Liu and Erika K Ramos. Their collaborative efforts have contributed to advancing research in the field of cancer diagnostics and therapeutics.

Conclusion

Golam Kibria's innovative work in the realm of cancer diagnostics and therapeutics exemplifies the impact of research and invention on healthcare. His contributions are paving the way for more effective cancer treatments and early detection methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…